Patents
Sitemap › C07 - Organic chemistry › C07K - Peptides › C07K 16 - Immunoglobulins, e.g. monoclonal or polyclonal antibodies
Patents for C07K 16 - Immunoglobulins, e.g. monoclonal or polyclonal antibodies (149,320)
04/2012
04/03/2012US8147832 Diagnosis, therapy od autoimmune disease
04/03/2012US8147831 Anti-CD19 antibodies
04/03/2012US8147829 Anti-IGR-1R antibodies and uses thereof
04/03/2012US8147828 Methods and compositions for modulation of blood-neural barrier
04/03/2012CA2572917C Look-through mutagenesis for developing altered polypeptides with enhanced properties
04/03/2012CA2567623C Isolation of allergen-specific immunoglobulin genes from human b-cells of atopic subjects
04/03/2012CA2454618C Methods for treating or preventing sclerotic disorders using cd2-binding agents
04/03/2012CA2353314C Mutants of the factor vii-activating protease and detection methods using specific antibodies
04/03/2012CA2347411C Virus-like particles for the induction of autoantibodies
04/03/2012CA2198461C Polynucleic acids isolated from a porcine reproductive and respiratory syndrome virus (prrsv), proteins encoded by the polynucleic acids, vaccines based on the proteins and/or polynucleic acids, a method of protecting a pig from a prrsv and a method of detecting a prrsv
03/2012
03/29/2012WO2012040518A2 Carrier immunoglobulins and uses thereof
03/29/2012WO2012040041A1 Purification of antibodies using simulated moving bed chromatography
03/29/2012WO2012038820A2 Immunochromatography devices, methods and kits
03/29/2012WO2012038609A1 Super-humanized antibodies
03/29/2012WO2012038606A1 Oncolytic adenoviral vectors coding for monoclonal anti - ctla - 4 antibodies
03/29/2012WO2012038573A1 Anti-ephrin-b2 antibody and use thereof
03/29/2012WO2012038504A2 Breast cancer therapeutics
03/29/2012WO2012038331A1 Assay for a type ii collagen biomarker
03/29/2012WO2012038315A1 Therapeutic factor viii antibodies
03/29/2012WO2012037616A1 Interferon-nu
03/29/2012WO2012010966A3 A combination pharmaceutical composition and methods of treating diabetes and metabolic disorders
03/29/2012WO2012007845A3 A method of increasing the effect of an activated-potentiated form of an antibody
03/29/2012WO2011159741A3 Tetranor-pgem/pgam specific immunogens, antibodies, tracers, assay kits and methods for making same
03/29/2012WO2011139974A3 Anti-pai-1 antibodies and methods of use thereof
03/29/2012WO2011112993A3 Methods of predicting and decreasing the risk of pregnancy loss
03/29/2012WO2011112935A3 Antibody fusion proteins with disrupted heparin-binding activity
03/29/2012WO2010142981A3 Composition and uses thereof
03/29/2012US20120079616 Npc1l1 (npc3) and methods of use thereof
03/29/2012US20120079613 Homeobox Transcription Factor BSX and Uses Thereof for Treating Diseases, in Particular Obesity
03/29/2012US20120078028 Antibody drug conjugates (adc) that bind to 191p4d12 proteins
03/29/2012US20120077964 Antagonists of pcsk9
03/29/2012US20120077963 Method for removing viruses from high concentration monoclonal antibody solution
03/29/2012US20120077962 Humanized anti-prostate stem cell antigen monoclonal antibody
03/29/2012US20120077732 Cyclic peptides and uses thereof
03/29/2012US20120077714 Mass Spectrometry Based Particle Separation
03/29/2012US20120077713 Collection and Methods for its Use
03/29/2012US20120077710 Method for an in vitro molecular evolution of antibody function
03/29/2012US20120077212 Methods of diagnosing als
03/29/2012US20120077207 CD86 and CD80 receptor competition assays
03/29/2012US20120076851 CHROMOSOME 3p21.3 GENES ARE TUMOR SUPPRESSORS
03/29/2012US20120076816 Novel malaria vaccine
03/29/2012US20120076815 Identification and characterization of racemases, definition of protein signatures, and a test for detecting d-amino acid and for screening molecules capable of inhibiting the activity of racemase, especially proline racemase
03/29/2012US20120076804 Cancer targeted innate immunity
03/29/2012US20120076803 Antibodies to troponin i and methods of use thereof
03/29/2012US20120076802 Human cytomegalovirus neutralising antibodies and use thereof
03/29/2012US20120076801 Human cytomegalovirus neutralising antibodies and use thereof
03/29/2012US20120076799 Antagonists of pcsk9
03/29/2012US20120076798 Antagonistic Human LIGHT-Specific Human Monoclonal Antibodies
03/29/2012US20120076796 Amino acid sequences directed against the angiopoietin/tie system and polypeptides comprising the same for the treatment of diseases and disorders related to angiogenesis
03/29/2012US20120076794 Host cell specific binding molecules capable of neutralizing viruses and uses thereof
03/29/2012US20120076792 Antibody selective for a tumor necrosis factor-related apoptosis-inducing ligand receptor and uses thereof
03/29/2012US20120076790 Anti-cd48 antibodies and uses thereof
03/29/2012US20120076789 Nucleic acid and corresponding protein entitled 121p1f1 useful in treatment and detection of cancer
03/29/2012US20120076787 Combination of a tnf-alpha antagonist and a vegf antagonist for use in the treatment or prevention of diseases of the eye
03/29/2012US20120076786 Bispecific antibodies
03/29/2012US20120076784 Highly concentrated, liquid formulations of anti-egfr antibodies
03/29/2012US20120076782 Generation and profiling of fully human hucal gold®-derived therapeutic antibodies specific for human cd38
03/29/2012US20120076778 Antibodies Against Insulin-Like Growth Factor I Receptor and Uses Thereof
03/29/2012US20120076772 Stabilization of immunoglobulins through aqueous formulation with histidine at weak acidic to neutral ph
03/29/2012US20120076758 Antibodies against west nile virus and therapeutic and prophylactic uses thereof
03/29/2012US20120076727 In Vivo Copper-Free Click Chemistry for Delivery of Therapeutic and/or Diagnostic Agents
03/29/2012US20120076724 Novel serpentine transmembrane antigens expressed in human cancers and uses thereof
03/29/2012CA2814780A1 Carrier immunoglobulins and uses thereof
03/29/2012CA2812727A1 Anti-ephrin b2 antibody and its use
03/29/2012CA2812416A1 Human b1 cells and uses thereof
03/29/2012CA2812093A1 Oncolytic adenoviral vectors coding for monoclonal anti - ctla - 4 antibodies
03/29/2012CA2812058A1 Dissociation of product-complexed contaminants in chromatography
03/29/2012CA2811706A1 Immunochromatography devices, methods, and kits
03/29/2012CA2811556A1 Breast cancer therapeutics
03/29/2012CA2811462A1 Super-humanized antibodies
03/29/2012CA2810909A1 Purification of antibodies using simulated moving bed chromatography
03/28/2012EP2434420A2 Systems and methods for biopolymer engineering
03/28/2012EP2434022A2 Use of A33 antigens and JAM-IT
03/28/2012EP2434019A1 Process for the production of fine chemicals
03/28/2012EP2433967A2 Humanised antibodies with anti-tumour activity
03/28/2012EP2433966A1 FGFR4 antibodies
03/28/2012EP2433965A2 Production of antibody formats and immunological applications of said formats
03/28/2012EP2433962A2 Identification of tumor-associated antigens for diagnosis and therapy
03/28/2012EP2433961A2 Identification of tumor-associated antigens for diagnosis and therapy
03/28/2012EP2433960A2 Identification of tumor-associated antigens for diagnosis and therapy
03/28/2012EP2433959A2 Identification of tumor-associated antigens for diagnosis and therapy
03/28/2012EP2433958A2 Identification of tumor-associated antigens for diagnosis and therapy
03/28/2012EP2433957A2 Identification of tumor-associated antigens for diagnosis and therapy
03/28/2012EP2433956A2 Identification of tumor-associated antigens for diagnosis and therapy
03/28/2012EP2433955A2 Identification of tumor-associated antigens for diagnosis and therapy
03/28/2012EP2433954A2 Identification of tumor-associated antigens for diagnosis and therapy
03/28/2012EP2433650A2 Administration of anti-CD3 antibodies in the treatment of autoimmune diseases
03/28/2012EP2433649A2 Treatment of multiple sclerosis (MS) with campath-1H
03/28/2012EP2433644A1 Breast cancer therapeutics
03/28/2012EP2432805A1 Modulation of pilr receptors to treat sepsis
03/28/2012EP2432804A1 Antibodies or fragments thereof directed against a staphylococcus aureus epitope of isaa or isab
03/28/2012EP2432803A2 Compositions and methods for the therapy and diagnosis of influenza
03/28/2012EP2432500A2 Engineered type iv pilin of clostridium difficile
03/28/2012EP2432476A1 Methods for treating or preventing ophthalmological diseases
03/28/2012EP2066349B1 Humanized anti-cd19 antibodies and their use in treatment of tumors, transplantation and autoimmune diseases
03/28/2012EP2021033B1 Il-1-alpha for use in a method of treatment of atherosclerotic plaques.
03/28/2012EP1846450B1 Antibodies that bind to epha2 and methods of use thereof
03/28/2012EP1690870B1 Marker peptide for alzheimer's disease
03/28/2012EP1517700B1 Mucin fusion polypeptide vaccines, compositions and methods of use thereof
03/28/2012EP1392866B1 Novel method for cloning variable domain sequences of immunological gene repertoire
1 ... 204 205 206 207 208 209 210 211 212 213 214 215 216 217 218 219 220 221 222 223 224 ... 1494